Related Experiment Video
Updated: Jul 15, 2025

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Deleterious heteroplasmic mitochondrial mutations are associated with an increased risk of overall and
Yun Soo Hong1, Stephanie L Battle1,2, Wen Shi1
1McKusick-Nathans Institute, Department of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Abstract:
Mitochondria carry their own circular genome and disruption of the mitochondrial genome is associated with various aging-related diseases. Unlike the nuclear genome, mitochondrial DNA (mtDNA) can be present at 1000 s to 10,000 s copies in somatic cells and variants may exist in a state of heteroplasmy, where only a fraction of the DNA molecules harbors a particular variant. We quantify mtDNA heteroplasmy in 194,871 participants in the UK Biobank and find that heteroplasmy is associated with a 1.5-fold increased risk of all-cause mortality. Additionally, we functionally characterize mtDNA single nucleotide variants (SNVs) using a constraint-based score, mitochondrial local constraint score sum (MSS) and find it associated with all-cause mortality, and with the prevalence and incidence of cancer and cancer-related mortality, particularly leukemia. These results indicate that mitochondria may have a functional role in certain cancers, and mitochondrial heteroplasmic SNVs may serve as a prognostic marker for cancer, especially for leukemia.
Insights
Mitochondrial DNA heteroplasmy is linked to a 1.5-fold higher risk of death. Specific mitochondrial variants also correlate with cancer risk and mortality, particularly leukemia.
Area of Science:
- Genetics
- Molecular Biology
- Gerontology
Background:
- Mitochondria possess their own genome (mtDNA), distinct from nuclear DNA.
- mtDNA variants can exist as heteroplasmy, with varying proportions of variant DNA molecules.
- Disruptions in mitochondrial DNA are implicated in aging and related diseases.
Purpose of the Study:
- To quantify mitochondrial DNA heteroplasmy in a large cohort.
- To investigate the association of mtDNA heteroplasmy and variants with all-cause mortality.
- To explore the role of mtDNA variants in cancer prevalence, incidence, and mortality.
Main Methods:
- Quantification of mtDNA heteroplasmy in 194,871 UK Biobank participants.
- Functional characterization of mtDNA single nucleotide variants (SNVs) using the mitochondrial local constraint score sum (MSS).
- Statistical analysis to determine associations with mortality and cancer outcomes.
Main Results:
- mtDNA heteroplasmy was associated with a 1.5-fold increased risk of all-cause mortality.
- The MSS score for mtDNA SNVs showed associations with all-cause mortality.
- mtDNA variants were linked to the prevalence, incidence, and mortality of cancer, especially leukemia.
Conclusions:
- Mitochondrial heteroplasmy is a significant risk factor for all-cause mortality.
- mtDNA variants may play a functional role in the development of certain cancers, notably leukemia.
- Mitochondrial heteroplasmic SNVs show potential as prognostic markers for cancer, particularly leukemia.
Related Concept Videos
Animal Mitochondrial Genetics
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mitochondria
Mutations
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes

